Oseltamivir

Respiratory

Respiratory · Neuraminidase inhibitor

Oseltamivir

Dose

75 mg PO BD × 5 days (treatment) within 48 h of onset; 75 mg OD × 10 days prophylaxis. Reduce if CrCl <60.

Use

Influenza A/B in high-risk or hospitalised patients.

Monitoring

Renal function, symptom trajectory, secondary bacterial infection.

Side effects

  • Nausea, vomiting
  • Headache
  • Neuropsychiatric events in adolescents (rare)

Always confirm dose against your local formulary / BNF before prescribing.

WardRound

WardRound

Clinical Decisions in Seconds